Nocion Therapeutics

Drug Discovery · Watertown, MA · Founded 2017 · Privately Held (backing)

Developer of a small molecule charged sodium channel designed to treat the conditions arising from neurogenic inflammation. Nocion Therapeutics is based in Watertown, MA and was founded in 2017. Its last reported valuation was $112 million in Aug 2021. It has raised $153 million across 3 recorded rounds; the latest was a $23 million early-stage round in Dec 2025.

Last reported valuation
$112.0M
Oct 2026
Priced at
—
Total raised
$153.0M
Last round
Early Stage VC
Dec 2025

Who backs Nocion Therapeutics?

16 investors
InvestorType
RA Capital ManagementAsset manager
F-Prime CapitalVenture capital
Eight RoadsAsset manager
Alexandria Venture InvestmentsOther
Canaan PartnersVenture capital
Morningside GroupVenture capital
Osage University PartnersVenture capital
Arkin CapitalFamily office
Mission BioCapitalVenture capital
Harvard UniversityOther
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nocion Therapeutics investors

16 investors are on record for Nocion Therapeutics, including RA Capital Management, F-Prime Capital, Eight Roads and Alexandria Venture Investments. By type, the record holds 5 venture capital firms and 2 asset managers. The early-stage round in Dec 2025 drew 13 investors.

Free account
More of Nocion Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Nocion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Nocion Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View